• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $STSS

    Sharps Technology Inc.

    Subscribe to $STSS
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

    IPO Year: 2022

    Exchange: NASDAQ

    Website: https://sharpstechnology.com

    Recent Analyst Ratings for Sharps Technology Inc.

    DatePrice TargetRatingAnalyst
    See more ratings

    Sharps Technology Inc. Press Releases

    Fastest customizable press release news feed in the world

    View All

    SkyAI Appoints Veteran Finance Executive Arthur Levine as Chief Financial Officer

    Mission-critical appointment with extensive public company, multinational, and emerging growth experience as SkyAI advances its agentic finance platformMarks the latest step in the Company's evolution as it continues building out its leadership team to support initiatives serving the Global South NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- SkyAI, Inc. (NASDAQ: "SKYA") ("SkyAI" or the "Company"), a financial technology company building agentic finance for the Global South, today announced the appointment of Arthur Levine as Chief Financial Officer, effective immediately. Mr. Levine will be a key member of the Executive Team as SkyAI builds out its infrastructure to support the next phase o

    5/29/26 8:30:00 AM ET
    $SKYA
    $STSS
    Blank Checks
    Finance
    Medical/Dental Instruments
    Health Care

    Sharps Technology Becomes SkyAI, Inc. with New Ticker Symbol "SKYA"; Establishing Category-defining Agentic Finance Platform Serving Global South

    Rebrand to SkyAI, Inc. to reflect evolution of the business to build a global agentic finance platformOpened operational headquarters in Hong Kong, a global hub for financial technology innovation and a base for licensing and world-class talent NEW YORK, May 27, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. ("STSS") today announced a strategic evolution of its business model - now building an agentic finance platform serving the Global South. In connection with this expansion, the Company has rebranded as SkyAI, Inc. ("SkyAI" or the "Company") and the Company expects its common stock will cease trading under the symbol "STSS" and will commence trading on the Nasdaq under the new ticker

    5/27/26 7:00:00 AM ET
    $SKYA
    $STSS
    Blank Checks
    Finance
    Medical/Dental Instruments
    Health Care

    Sharps Technology Reports Continued Growth in Q1 2026 Highlighting Strengthened Balance Sheet and Strong Treasury Execution

    NEW YORK, May 15, 2026 /PRNewswire/ -- Sharps Technology, Inc. ("STSS" or the "Company"), a medical device sales and distribution company that has adopted a Solana-based digital asset treasury strategy, has announced financial results for the first quarter ended March 31, 2026, and provided an update on the continued execution of its treasury and infrastructure strategy. "The first quarter of 2026 shows that the strategic repositioning we completed last year is continuing to translate into meaningful financial performance," said Paul K. Danner, Executive Chairman of Sharps. "We

    5/15/26 8:00:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Adopts Limited Duration Stockholder Rights Plan

    MELVILLE, N.Y., May 14, 2026 /PRNewswire/ -- Sharps Technology, Inc. ("Sharps Technology" or the "Company") (NASDAQ:STSS) today announced that its Board of Directors has adopted a limited duration stockholder rights plan (the "Rights Plan") to protect stockholder interests. The Board adopted the Rights Plan following recent accumulations of the Company's common stock in order to protect the interests of the Company and its stockholders. The Rights Plan is intended to better ensure that all stockholders have the opportunity to realize the value of their investment. Further, it is

    5/14/26 6:07:00 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Reports 2025 Year-End Results and Highlights Continued Execution of Solana Treasury Strategy

    Over 2 Million SOL Held with Approximately 95% Staked at ~7% Gross Annualized YieldTotal Assets of $269.1 Million, Up from $7.3 Million at Year-End 2024Expanded Solana Ecosystem Partnerships Including Coinbase, Crypto.com, BitGo, and Jupiter NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. ("Sharps" or the "Company"), a medical device sales and distribution company that has adopted a Solana-based digital asset treasury strategy, has announced financial results for the year ended December 31, 2025, and provided an update on the continued execution of its treasury and infrastructure strategy. The Company entered 2025 as a capital-constrained medical device manuf

    4/6/26 7:00:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology and The Tie Announce Strategic Collaboration to Advance Institutional Participation in the Solana Ecosystem

    NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. ("STSS" or the "Company") (NASDAQ:STSS), a medical device company with a Solana digital asset treasury strategy, and The Tie, Inc. ("The Tie"), the leading provider of institutional-grade digital asset analytics, compliant communications, and infrastructure services, today announced a strategic collaboration to strengthen Solana's institutional infrastructure and expand institutional access to the ecosystem. Under the collaboration, STSS will delegate a portion of its SOL treasury holdings, currently more than 2 million SOL, to Stakin by The Tie, which operates non-custodial validator infrastructure across 40+ proof-o

    2/25/26 9:00:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology and BitGo Announce Collaboration to Advance Solana Treasury Strategy

    NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. ("STSS" or the "Company") (NASDAQ:STSS), a medical device company with a Solana (SOL) digital asset treasury strategy, and BitGo Bank & Trust, National Association ("BitGo"), the digital asset infrastructure company, today announced a strategic collaboration under which STSS will expand and further institutionalize its Solana treasury strategy through BitGo's services. As part of this arrangement, STSS intends to utilize BitGo's institutional-grade qualified custody through its OCC regulated entity, BitGo Bank & Trust, National Association. In addition, STSS intends to leverage BitGo's Solana staking validator to earn com

    2/5/26 7:00:00 AM ET
    $BTGO
    $STSS
    Finance: Consumer Services
    Finance
    Medical/Dental Instruments
    Health Care

    Sharps Technology Reports Strong Solana Staking Income

    NEW YORK, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. ("STSS" or the "Company"), a medical device company implementing a Solana-based digital asset treasury strategy, today issued an update on its treasury and recent operational highlights. Treasury Updates Staking: Since inception, STSS's validator partners have generated ~7% gross annual percentage yield (APY) before fees, outperforming the Solana network average. Nearly all of the Company's SOL holdings are currently staked.Balance Sheet: STSS continues to maintain sufficient operating capital and has no corporate debt. Recent Operational Highlights In January, STSS announced a lock-up agreement with its Strategic Advi

    1/26/26 7:00:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sichenzia Ross Ference Carmel LLP Achieves Firm Record Advising on Over 170 Transactions Totaling Over $14 Billion in 2025

    NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Sichenzia Ross Ference Carmel LLP ("SRFC") reported that in 2025 it advised on over 170 announced transactions, with the total value of these transactions exceeding $14 billion, far surpassing the firm's strong performance in 2024. The transactions, on behalf of various market participants, such as issuers, underwriters and investors, included initial public offerings, secondary public offerings, registered direct offerings, private placements, mergers, acquisitions and cryptocurrency transactions. In October of 2025, for the fifth consecutive quarter, SRFC was ranked first in the nation for issuer counsel among securities law firms in Placement

    1/20/26 8:00:00 AM ET
    $EMIS
    $NCRA
    $SOUL
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Farming/Seeds/Milling
    Consumer Staples

    Sharps Technology Strengthens Market Confidence with Advisor Lock-Up Agreement

    NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ:STSS) today announced that it has entered into a 90-day lock-up agreement with SOL Markets (the "Strategic Advisor"), pursuant to which SOL Markets has agreed to restrict sales of its advisory warrants and any underlying shares. The lock-up reflects strong conviction in STSS's execution roadmap and reinforces alignment between the parties. This comes after the company's recent announcement that its Board of Directors approved a share buyback program for up to $100 million. Under the terms of the agreement, the Strategic Advisor has voluntarily agreed not to sell, transfer, assign, pledge, hedge, or otherwise dispo

    1/16/26 7:00:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Levine Arthur

    3 - SkyAI, Inc. (0001737995) (Issuer)

    6/3/26 4:30:48 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Large owner Falconx Holdings Ltd sold $1,490,755 worth of shares (769,320 units at $1.94) and exercised 461,538 in-the-money shares at a strike of $0.00 (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    2/13/26 4:45:04 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    New insider Falconx Holdings Ltd claimed ownership of 769,230 shares (SEC Form 3)

    3 - Sharps Technology Inc. (0001737995) (Issuer)

    2/13/26 4:10:05 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Large owner Saba Capital Management, L.P. sold $86,371 worth of shares (37,182 units at $2.32) (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    1/20/26 5:55:14 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Large owner Saba Capital Management, L.P. sold $240,010 worth of shares (107,465 units at $2.23) (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    1/15/26 12:48:07 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    New insider Saba Capital Management, L.P. claimed ownership of 1,656,635 shares (SEC Form 3)

    3 - Sharps Technology Inc. (0001737995) (Issuer)

    1/15/26 12:33:16 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Chief Investment Officer Zhang Yuwen

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    10/6/25 4:32:03 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    New insider Zhang Yuwen claimed ownership of 14,040 shares (SEC Form 3)

    3 - Sharps Technology Inc. (0001737995) (Issuer)

    10/6/25 4:30:25 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Director Ruemler Timothy James sold $334,786 worth of shares (20,000 units at $16.74), decreasing direct ownership by 50% to 20,218 units (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    8/28/25 9:21:49 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Director Ruemler Timothy James increased direct ownership by 294% to 40,218 units (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    8/26/25 9:45:47 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Inc. SEC Filings

    View All

    Sharps Technology Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

    8-K - SkyAI, Inc. (0001737995) (Filer)

    6/1/26 8:15:14 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits

    8-K - SkyAI, Inc. (0001737995) (Filer)

    5/29/26 4:30:19 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Sharps Technology Inc.

    SCHEDULE 13G/A - Sharps Technology Inc. (0001737995) (Subject)

    5/15/26 9:30:13 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Sharps Technology Inc.

    10-Q - Sharps Technology Inc. (0001737995) (Filer)

    5/14/26 5:30:41 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    SEC Form 10-K filed by Sharps Technology Inc.

    10-K - Sharps Technology Inc. (0001737995) (Filer)

    3/31/26 4:46:44 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update

    8-K - Sharps Technology Inc. (0001737995) (Filer)

    2/23/26 4:15:27 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    SEC Form SCHEDULE 13D filed by Sharps Technology Inc.

    SCHEDULE 13D - Sharps Technology Inc. (0001737995) (Subject)

    2/13/26 4:15:01 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    SEC Form EFFECT filed by Sharps Technology Inc.

    EFFECT - Sharps Technology Inc. (0001737995) (Filer)

    2/2/26 12:15:19 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Sharps Technology Inc.

    SCHEDULE 13G/A - Sharps Technology Inc. (0001737995) (Subject)

    1/23/26 6:09:54 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - Sharps Technology Inc. (0001737995) (Filer)

    1/16/26 4:30:44 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ruemler Timothy James increased direct ownership by 294% to 40,218 units (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    8/26/25 9:45:47 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Chief Financial Officer Crescenzo Andrew R. bought $256,400 worth of Option (40,000 units at $6.41) (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    8/26/25 9:24:34 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Director Monroe Jason L. bought $512,800 worth of Option (80,000 units at $6.41) (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    8/26/25 9:24:36 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Director Danner Paul K bought $2,564,000 worth of Option (400,000 units at $6.41) (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    8/26/25 9:24:30 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Director Simpson Brenda Baird bought $128,200 worth of Option (20,000 units at $6.41) (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    8/26/25 9:24:30 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Director Christiansen Soren Bo bought $512,800 worth of Option (80,000 units at $6.41) (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    8/26/25 9:24:31 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Director Hayes Robert Michael bought $641,000 worth of Option (100,000 units at $6.41) (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    8/26/25 9:24:32 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Director Danner Paul K bought $100 worth of Series B Preferred Stock (5 units at $20.00) (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    7/18/25 2:48:21 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Chief Executive Officer Hayes Robert Michael bought $10,750 worth of shares (300,000 units at $0.04), increasing direct ownership by 297% to 400,882 units (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    4/1/25 5:24:02 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Amendment: Chief Executive Officer Hayes Robert Michael bought $10,072 worth of shares (5,000 units at $2.01), increasing direct ownership by 115% to 9,358 units (SEC Form 4)

    4/A - Sharps Technology Inc. (0001737995) (Issuer)

    12/6/24 5:15:10 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Inc. Leadership Updates

    Live Leadership Updates

    View All

    Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery Systems

    NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ:STSS) (NASDAQ:STSSW), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is working to create new sales and distribution opportunities through the addition of new North American 3PL partnerships to expand its reach into the global healthcare market. These additional third-party logistics partnerships, along with a developing alliance with Roncadelle Operations, a driving force in the development of safe, novel medical drug delivery devices, would combine the strengths and capabilities of the two companies to develop, market and distribute unique dru

    2/16/24 2:42:54 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of Sales

    Key appointment with demonstrated experience in leading sales and marketing operations to oversee commercial initiatives as the Company launches its specialty smart safety syringe products to the market Product qualification and sales initiatives underway as company prepares for U.S. commercial operations NEW YORK, July 12, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the "Company") (NASDAQ: "STSS" and "STSSW"), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, is pleased to announce the appointment of Ben Scheu as Senior Director of Sales to lead commercial operations as the Company prepares to launch products to the market.

    7/12/23 8:33:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Appoints Justin Page as Vice President of Technical Operations

    NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the "Company", "Sharps") (NASDAQ: "STSS" and "STSSW"), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, appoints Justin Page as Vice President of Technical Operations. In his role, Mr. Page will be responsible for managing all aspects of Sharps' engineering operations. His primary focus will be to provide the leadership and technical expertise to support the prefillable syringe collaboration with Nephron Pharmaceuticals at the InjectEZ facility. These efforts will include the support for the injection molding of the specialty components and the high speed assembl

    2/9/23 9:21:23 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Sharps Technology Inc.

    SC 13G/A - Sharps Technology Inc. (0001737995) (Subject)

    11/13/24 4:50:17 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Sharps Technology Inc.

    SC 13G/A - Sharps Technology Inc. (0001737995) (Subject)

    10/9/24 9:01:14 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Sharps Technology Inc.

    SC 13G - Sharps Technology Inc. (0001737995) (Subject)

    2/14/24 11:14:11 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Sharps Technology Inc.

    SC 13G - Sharps Technology Inc. (0001737995) (Subject)

    1/9/24 9:06:07 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Inc. Financials

    Live finance-specific insights

    View All

    Sharps Technology Adopts Limited Duration Stockholder Rights Plan

    MELVILLE, N.Y., May 14, 2026 /PRNewswire/ -- Sharps Technology, Inc. ("Sharps Technology" or the "Company") (NASDAQ:STSS) today announced that its Board of Directors has adopted a limited duration stockholder rights plan (the "Rights Plan") to protect stockholder interests. The Board adopted the Rights Plan following recent accumulations of the Company's common stock in order to protect the interests of the Company and its stockholders. The Rights Plan is intended to better ensure that all stockholders have the opportunity to realize the value of their investment. Further, it is

    5/14/26 6:07:00 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology, Inc. Acquires Over 2 Million SOL, the Native Asset of Solana, the Fastest and Most Used Public Blockchain

    NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Sharps Technology, Inc. (the "Company" or "Sharps Technology") (Nasdaq: "STSS" and "STSSW") today announced its first acquisition of Solana ("SOL") tokens as part of its digital asset treasury strategy under which the principal holding will be SOL, the native digital asset of the Solana blockchain. Funded from the Company's recent PIPE equity raise, Sharps Technology now holds over 2 million SOL, creating a SOL treasury currently valued north of $400M. Sharps Technology intends to provide regular updates on its SOL holdings and performan

    9/2/25 7:00:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / June 7, 2024 / RedChip Companies will air interviews with Soligenix, Inc. (NASDAQ:SNGX) and Sharps Technology Inc. (NASDAQ:STSS) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, June 8, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:Soligenix: https://www.redchip.com/assets/access/sngx_accessSharps Technology: https://www.redchip.com/assets/access/stss_accessIn an exclusive interview, Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix, appears on the RedChip Small Stocks Big Money™ show on B

    6/7/24 9:00:00 AM ET
    $SNGX
    $STSS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments

    Sharps Technology, Reviva Pharmaceuticals, and American Resources Corp. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / September 29, 2023 / RedChip Companies will air interviews with Sharps Technology, Inc. (NASDAQ:STSS), Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) and American Resources Corp. (NASDAQ:AREC) on The RedChip Money Report®, a sponsored program on Bloomberg TV, this Saturday, September 30, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:Sharps Technology: https://www.redchip.com/assets/access/stss_accessReviva Pharmaceuticals: https://www.redchip.com/assets/access/rvph_accessAmerican Resources Corp: https://www.redchip.com/assets/access/arec_accessAbout The RedChip

    9/29/23 9:00:00 AM ET
    $AREC
    $RVPH
    $STSS
    Coal Mining
    Energy
    Biotechnology: Pharmaceutical Preparations
    Health Care

    RedChip Launches 'Small Stocks, Big Money' Podcast

    New podcast series shines a spotlight on undervalued small-cap and microcap stocksORLANDO, FL / ACCESSWIRE / August 2, 2023 / RedChip Companies, a renowned international investor relations firm specializing in microcap and small-cap companies,announce the launch of its much-anticipated podcast series, "Small Stocks, Big Money."Hosted by RedChip CEO Dave Gentry and Associate Director Barrett Boone, the "Small Stocks, Big Money" podcast aims to offer a first-hand look at undiscovered small-cap and microcap stocks before they catch the attention of bigger Wall Street players. The series features in-depth interviews with executives from some of the top names in smaller cap stocks, providing list

    8/2/23 12:45:00 PM ET
    $BFRG
    $LTRN
    $RVPH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments
    Pharmaceuticals and Biotechnology

    Sharps Technology, Inc. and BullFrog AI Holdings, Inc. Interviews to Air on Bloomberg TV on the RedChip Money Report(R)

    ORLANDO, FL / ACCESSWIRE / May 19, 2023 / RedChip Companies will air new interviews with Sharps Technology, Inc. (NASDAQ:STSS, STSSW))) and BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW))) on The RedChip Money Report® on Bloomberg TV, this Saturday, May 20, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:Sharps Technology, Inc.: https://www.stssinfo.com/interview_accessBullFrog AI Holdings, Inc.: https://bfrginfo.com/interview_accessAbout The RedChip Money Report®The RedChip Money Report® is produced by RedChip Companies Inc., an international Investor Relations and media firm with 30 years' ex

    5/19/23 9:00:00 AM ET
    $BFRG
    $STSS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments

    BullFrog AI and Sharps Technology Interviews to Air on Bloomberg U.S. on the RedChip Money Report(R)

    ORLANDO, FL / ACCESSWIRE / April 5, 2023 / RedChip Companies will air new interviews with BullFrog AI (NASDAQ:BFRG) and Sharps Technology (NASDAQ:STSS) on The RedChip Money Report® on Bloomberg TV, this Saturday, April 8, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:BullFrog AI (NASDAQ:BFRG): https://bfrginfo.com/interview_accessSharps Technology (NASDAQ:STSS): https://www.stssinfo.com/interview_accessAbout The RedChip Money Report®The RedChip Money Report® is produced by RedChip Companies Inc., an international Investor Relations and media firm with 30 years' experience focused on Discoverin

    4/5/23 7:05:00 AM ET
    $BFRG
    $STSS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments